The Securities and Exchange Commission announced insider trading charges against Congressman Christopher Collins, his son, and another associated individual. Collins allegedly tipped off his son, using information received in confidence as the director of a biotech company. Two additional associated individuals settled charges with the SEC.
SEC press release | Collins complaint | D. Zarsky complaint | L. Zarsky complaint